BVX - Bovie Medical Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
5.15
0.00 (0.00%)
At close: 4:00PM EDT

5.15 +0.01 (0.19%)
After hours: 4:00PM EDT

Stock chart is not supported by your current browser
Previous Close5.15
Open5.15
Bid4.85 x 1000
Ask0.00 x 1000
Day's Range5.04 - 5.18
52 Week Range2.17 - 5.49
Volume76,131
Avg. Volume119,453
Market Cap169.332M
Beta-1.42
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • MarketWatch8 days ago

    Bovie Medical's stock jumps after deal to sell core business

    Bovie Medical Corp.'s stock (bvx) soared 10% toward a 20-month high in premarket trade Monday, after the medical device company said it reached a deal to sell its "core" business and the Bovie brand for $97 million in cash to Symmetry Surgical Inc. As part of the deal, which is expected to close in the third quarter of 2018, Bovie said it will enter into transition services, patent licensing, disposables supply and generator manufacturing and supply agreements with Symmetry. "This is a milestone moment for the Company, one that creates significant value for our shareholders by significantly enhancing our balance sheet with the addition of more than $70 million in estimated net cash proceeds after taxes and transaction related expenses and allowing us to further focus the organization on our strategic objective of commercializing our J-Plasma/Renuvion technology in the cosmetic surgery market," said Chief Executive Charlie Goodwin.

  • Benzinga2 months ago

    Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 14) ABIOMED, Inc. (NASDAQ: ABMD ) Bio-Rad Laboratories, Inc. (NYSE: ...

  • Associated Press2 months ago

    Bovie: 1Q Earnings Snapshot

    The Clearwater, Florida-based company said it had a loss of 3 cents per share. The medical device maker posted revenue of $9.9 million in the period. Bovie expects full-year revenue in the range of $41 ...

  • Associated Press4 months ago

    Bovie reports 4Q loss

    On a per-share basis, the Purchase, New York-based company said it had a loss of 3 cents. The medical device maker posted revenue of $11.3 million in the period. For the year, the company reported that ...

  • Capital Cube8 months ago

    ETFs with exposure to Bovie Medical Corp. : November 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Bovie Medical Corp. Here are 5 ETFs with the largest exposure to BVX-US. Comparing the performance and risk of Bovie Medical Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Associated Press8 months ago

    Bovie reports 3Q loss

    On a per-share basis, the Purchase, New York-based company said it had a loss of 4 cents. The medical device maker posted revenue of $9.3 million in the period. Bovie expects full-year revenue in the range ...

  • What does Bovie Medical Corporation’s (BVX) Balance Sheet Tell Us Abouts Its Future?
    Simply Wall St.9 months ago

    What does Bovie Medical Corporation’s (BVX) Balance Sheet Tell Us Abouts Its Future?

    While small-cap stocks, such as Bovie Medical Corporation (AMEX:BVX) with its market cap of USD $123.13M, are popular for their explosive growth, investors should also be aware of their balanceRead More...

  • Capital Cube9 months ago

    ETFs with exposure to Bovie Medical Corp. : October 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Bovie Medical Corp. Here are 5 ETFs with the largest exposure to BVX-US. Comparing the performance and risk of Bovie Medical Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Associated Press11 months ago

    Bovie reports 2Q loss

    On a per-share basis, the Purchase, New York-based company said it had a loss of 4 cents. The medical device maker posted revenue of $9.8 million in the period. Bovie expects full-year revenue in the range ...